Cargando…
Persistent SARS-CoV-2-positive over 4 months in a COVID-19 patient with CHB
In recent months, the novel coronavirus disease 2019 (COVID-19) pandemic has become a major public health crisis with takeover more than 1 million lives worldwide. The long-lasting existence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has not yet been reported. Herein, we report...
Autores principales: | Li, Wenyuan, Huang, Beibei, Shen, Qiang, Jiang, Shouwei, Jin, Kun, Ning, Ling, Liu, Lei, Li, Lei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
De Gruyter
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8114950/ https://www.ncbi.nlm.nih.gov/pubmed/34013047 http://dx.doi.org/10.1515/med-2021-0283 |
Ejemplares similares
-
Study on Post-Treatment Relapse in HBeAg Positive CHB Patients
por: Lu, Junfeng, et al.
Publicado: (2015) -
Persisting Neutralizing Activity to SARS-CoV-2 over Months in Sera of COVID-19 Patients
por: Flehmig, Bertram, et al.
Publicado: (2020) -
Virologic and clinical characteristics of HBV genotypes/subgenotypes in 487 Chinese pediatric patients with CHB
por: Zhong, Yan-Wei, et al.
Publicado: (2011) -
Gwen Douglas, MB ChB, FRCPsych
por: Shoenberg, Peter
Publicado: (2022) -
The antibody response to SARS-CoV-2 infection persists over at least 8 months in symptomatic patients
por: Levi, Riccardo, et al.
Publicado: (2021)